drugset / Trial / NCT00802360
MENOPUR® Versus FOLLISTIM®
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles
Timeline
- Start
- 2008-12
- Primary completion
- 2009-11
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Follitropin beta | Protein / enzyme biologic | 225 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 225 iu | Subcutaneous |
| Subject | Progesterone | Other / unclassified | 50 mg | Other |
| Subject | Progesterone | Other / unclassified | 100 mg | Other |
| Background | Ganirelix | Protein / enzyme biologic | 250 ug | Subcutaneous |